Published in Neurosci Lett on November 06, 2007
Cell based therapies for ischemic stroke: from basic science to bedside. Prog Neurobiol (2013) 1.39
MRI identification of white matter reorganization enhanced by erythropoietin treatment in a rat model of focal ischemia. Stroke (2009) 1.19
Human microglia transplanted in rat focal ischemia brain induce neuroprotection and behavioral improvement. PLoS One (2010) 1.07
Generation of a novel transgenic mouse model for bioluminescent monitoring of survivin gene activity in vivo at various pathophysiological processes: survivin expression overlaps with stem cell markers. Am J Pathol (2010) 0.93
Early Exercise Protects against Cerebral Ischemic Injury through Inhibiting Neuron Apoptosis in Cortex in Rats. Int J Mol Sci (2013) 0.92
Lateral intracerebroventricular injection of Apelin-13 inhibits apoptosis after cerebral ischemia/reperfusion injury. Neural Regen Res (2015) 0.87
Antioxidant and anti-inflammatory effects of intravenously injected adipose derived mesenchymal stem cells in dogs with acute spinal cord injury. Stem Cell Res Ther (2015) 0.83
Trophic factors and stem cells for promoting recovery in stroke. J Vasc Interv Neurol (2010) 0.81
Time point expression of apoptosis regulatory proteins in a photochemically-induced focal cerebral ischemic rat brain. Chonnam Med J (2011) 0.79
Comparison of intracerebral transplantation effects of different stem cells on rodent stroke models. Cell Biochem Funct (2015) 0.78
Updates in the pathophysiological mechanisms of Parkinson's disease: Emerging role of bone marrow mesenchymal stem cells. World J Stem Cells (2016) 0.75
The Vascular Endothelial Growth Factors-Expressing Character of Mesenchymal Stem Cells Plays a Positive Role in Treatment of Acute Lung Injury In Vivo. Mediators Inflamm (2016) 0.75
12 hours after cerebral ischemia is the optimal time for bone marrow mesenchymal stem cell transplantation. Neural Regen Res (2015) 0.75
Treadmill exercise enhances therapeutic potency of transplanted bone mesenchymal stem cells in cerebral ischemic rats via anti-apoptotic effects. BMC Neurosci (2015) 0.75
Dec1 and Dec2 are regulators of the mammalian molecular clock. Nature (2002) 3.75
The Rab8 GTPase regulates apical protein localization in intestinal cells. Nature (2007) 3.01
Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res (2003) 2.47
Comparative genome analysis of Lactobacillus reuteri and Lactobacillus fermentum reveal a genomic island for reuterin and cobalamin production. DNA Res (2008) 2.37
Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin. J Pharmacol Exp Ther (2002) 2.36
Recognition of dileucine-based sorting signals from HIV-1 Nef and LIMP-II by the AP-1 gamma-sigma1 and AP-3 delta-sigma3 hemicomplexes. J Cell Biol (2003) 2.24
Structural basis for acidic-cluster-dileucine sorting-signal recognition by VHS domains. Nature (2002) 2.09
Apparent diffusion coefficient of human brain tumors at MR imaging. Radiology (2005) 1.97
Acquired resistance to erlotinib in A-431 epidermoid cancer cells requires down-regulation of MMAC1/PTEN and up-regulation of phosphorylated Akt. Cancer Res (2007) 1.94
Identification of a novel RNA silencing suppressor, NSs protein of Tomato spotted wilt virus. FEBS Lett (2002) 1.66
Posterolateral protrusion of the vertebral artery over the posterior arch of the atlas: quantitative anatomical study using three-dimensional computed tomography angiography. J Neurosurg Spine (2008) 1.64
Cerebral sinovenous thrombosis after closed head injury. J Trauma (2009) 1.61
Simultaneous cranial and spinal subdural hematoma. Neurol Med Chir (Tokyo) (2005) 1.59
Comprehensive analysis of chemotactic factors for bone marrow mesenchymal stem cells. Stem Cells Dev (2007) 1.49
Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes. J Biol Chem (2002) 1.48
Monoallelic BUB1B mutations and defective mitotic-spindle checkpoint in seven families with premature chromatid separation (PCS) syndrome. Am J Med Genet A (2006) 1.48
Enhancement of periodontal tissue regeneration by transplantation of bone marrow mesenchymal stem cells. J Periodontol (2004) 1.44
Recurrent severe mitral regurgitation due to left ventricular apical wall motion abnormality caused by coronary vasospastic angina: a case report. J Cardiol (2006) 1.41
Experimental Tooth Movement Into New Bone Area Regenerated by Use of Bone Marrow-Derived Mesenchymal Stem Cells. Cleft Palate Craniofac J (2013) 1.40
Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin. Mol Pharmacol (2003) 1.39
Multiple mechanisms regulate circadian expression of the gene for cholesterol 7alpha-hydroxylase (Cyp7a), a key enzyme in hepatic bile acid biosynthesis. J Biol Rhythms (2007) 1.35
CT perfusion imaging in the syndrome of the sinking skin flap before and after cranioplasty. Clin Neurol Neurosurg (2006) 1.34
Lactobacillus hayakitensis, L. equigenerosi and L. equi, predominant lactobacilli in the intestinal flora of healthy thoroughbreds. Anim Sci J (2009) 1.32
DEC1 modulates the circadian phase of clock gene expression. Mol Cell Biol (2008) 1.31
Identification of mesenchymal stem cell (MSC)-transcription factors by microarray and knockdown analyses, and signature molecule-marked MSC in bone marrow by immunohistochemistry. Genes Cells (2009) 1.27
Activation of TGF-beta/activin signalling resets the circadian clock through rapid induction of Dec1 transcripts. Nat Cell Biol (2008) 1.24
Sensitivity of breast cancer cells to erlotinib depends on cyclin-dependent kinase 2 activity. Mol Cancer Ther (2007) 1.23
Phase I trial of a personalized peptide vaccine for patients positive for human leukocyte antigen--A24 with recurrent or progressive glioblastoma multiforme. J Clin Oncol (2010) 1.23
Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T. Eur J Radiol (2010) 1.23
Basic helix-loop-helix protein DEC1 promotes chondrocyte differentiation at the early and terminal stages. J Biol Chem (2002) 1.23
Transforming growth factor-beta promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1. Cancer Res (2007) 1.21
Molecular markers distinguish bone marrow mesenchymal stem cells from fibroblasts. Biochem Biophys Res Commun (2005) 1.19
Alveolar bone marrow as a cell source for regenerative medicine: differences between alveolar and iliac bone marrow stromal cells. J Bone Miner Res (2004) 1.19
Functional analysis of the basic helix-loop-helix transcription factor DEC1 in circadian regulation. Interaction with BMAL1. Eur J Biochem (2004) 1.17
Phase II study of single-agent bevacizumab in Japanese patients with recurrent malignant glioma. Jpn J Clin Oncol (2012) 1.16
Behavior of transplanted bone marrow-derived mesenchymal stem cells in periodontal defects. J Periodontol (2006) 1.14
Basic-helix-loop-helix (bHLH) transcription factor DEC2 negatively regulates vascular endothelial growth factor expression. Genes Cells (2008) 1.14
A new technique to expand human mesenchymal stem cells using basement membrane extracellular matrix. Biochem Biophys Res Commun (2004) 1.12
Expression of the gene for Dec2, a basic helix-loop-helix transcription factor, is regulated by a molecular clock system. Biochem J (2004) 1.11
Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis. Cancer (2003) 1.10
Depression or apathy and functional recovery after stroke. Int J Geriatr Psychiatry (2007) 1.10
A novel autofeedback loop of Dec1 transcription involved in circadian rhythm regulation. Biochem Biophys Res Commun (2004) 1.10
Tissue-specific disruption of rhythmic expression of Dec1 and Dec2 in clock mutant mice. J Biol Rhythms (2005) 1.09
Xanthogranuloma in the suprasellar region. Neurol Med Chir (Tokyo) (2009) 1.09
Post-stroke depression and apathy: Interactions between functional recovery, lesion location, and emotional response. Psychogeriatrics (2011) 1.07
Wnt-5a signaling is correlated with infiltrative activity in human glioma by inducing cellular migration and MMP-2. Cancer Sci (2011) 1.07
Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor beta. Cancer Immunol Immunother (2009) 1.06
Effects of fasting and re-feeding on the expression of Dec1, Per1, and other clock-related genes. J Biochem (2006) 1.06
Role of PROPELLER diffusion-weighted imaging and apparent diffusion coefficient in the evaluation of pituitary adenomas. Eur J Radiol (2010) 1.06
Transcriptional repression by the basic helix-loop-helix protein Dec2: multiple mechanisms through E-box elements. Int J Mol Med (2007) 1.04
Common missense variant of monocarboxylate transporter 9 (MCT9/SLC16A9) gene is associated with renal overload gout, but not with all gout susceptibility. Hum Cell (2013) 1.02
PERIOD1 (PER1) has anti-apoptotic effects, and PER3 has pro-apoptotic effects during cisplatin (CDDP) treatment in human gingival cancer CA9-22 cells. Eur J Cancer (2011) 1.00
Usability of a microtapered needle (TN3305) for insulin treatment in japanese patients with diabetes mellitus: a comparative clinical study with a standard thin wall needle. Diabetes Technol Ther (2006) 1.00
Clinical presentation and treatment of distal posterior inferior cerebellar artery aneurysms. Neurosurg Rev (2010) 0.99
Anti-apoptotic effect of the basic helix-loop-helix (bHLH) transcription factor DEC2 in human breast cancer cells. Genes Cells (2010) 0.99
Change in the composition of the microflora on vacuum-packaged beef during chiller storage. Int J Food Microbiol (2002) 0.99
PROP1 coexists with SOX2 and induces PIT1-commitment cells. Biochem Biophys Res Commun (2009) 0.99
Morphological differences between ruptured and unruptured cases in middle cerebral artery aneurysms. Neurosurgery (2008) 0.99
Magnetic resonance spectroscopic detection of lactate is predictive of a poor prognosis in patients with diffuse intrinsic pontine glioma. Neuro Oncol (2011) 0.99
Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling. Kidney Int (2013) 0.99
Intradiploic arachnoid cyst identified by diffusion-weighted magnetic resonance imaging--case report. Neurol Med Chir (Tokyo) (2002) 0.99
The BHLH transcription factor DEC1 plays an important role in the epithelial-mesenchymal transition of pancreatic cancer. Int J Oncol (2012) 0.98
Stem cells in dentistry--part I: stem cell sources. J Prosthodont Res (2012) 0.97
Involvement of carnitine/organic cation transporter OCTN1/SLC22A4 in gastrointestinal absorption of metformin. J Pharm Sci (2013) 0.97
The basic helix-loop-helix proteins differentiated embryo chondrocyte (DEC) 1 and DEC2 function as corepressors of retinoid X receptors. Mol Pharmacol (2009) 0.97
Selection of common markers for bone marrow stromal cells from various bones using real-time RT-PCR: effects of passage number and donor age. Tissue Eng (2007) 0.97
Spinal epidural granulocytic sarcoma in a child precedent to clinical manifestation of acute myeloid lymphoma: case report. Neurol Med Chir (Tokyo) (2009) 0.97
Heterophilic binding of the adhesion molecules poliovirus receptor and immunoglobulin superfamily 4A in the interaction between mouse spermatogenic and Sertoli cells. Biol Reprod (2007) 0.97
Rhythmic expression of DEC1 and DEC2 in peripheral tissues: DEC2 is a potent suppressor for hepatic cytochrome P450s opposing DBP. Genes Cells (2004) 0.97
Tentorial dural arteriovenous malformation manifesting as trigeminal neuralgia treated by stereotactic radiosurgery: A case report. Surg Neurol (2006) 0.96
Solitary brain metastasis from renal cell carcinoma 15 years after nephrectomy: case report. Neurol Med Chir (Tokyo) (2005) 0.96
Basic helix-loop-helix transcription factor DEC1 negatively regulates cyclin D1. J Pathol (2011) 0.96
PERIOD1 is an anti-apoptotic factor in human pancreatic and hepatic cancer cells. J Biochem (2009) 0.96
Meningioangiomatosis occurring in a young male without neurofibromatosis: with special reference to its histogenesis and loss of heterozygosity in the NF2 gene region. Am J Surg Pathol (2002) 0.96
Natural course of incidentally found nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow-up examination. J Neurosurg (2006) 0.95